Ex Parte SCHRODER - Page 3


              Appeal No. 2000-2076                                                      Page 3                       
              Application No. 08/481,131                                                                                

                 (4)    applicants’ Appeal Brief (Paper No. 29);                                                        
                 (5)    the Examiner’s Answer (Paper No. 30); and                                                       
                 (6)    applicants’ Reply Brief (Paper No. 31).                                                         
                 On consideration of the record, including the above-listed materials, we reverse the                   
              examiner’s rejection under 35 U.S.C. § 112, first paragraph.                                              


                                                    DISCUSSION                                                          
                     The PTO has the initial burden of presenting evidence or reasons why persons                       
              skilled in the art would not recognize in applicant’s disclosure a description of the                     
              invention defined by the claims.  In re Wertheim, 541 F.2d 257, 263, 191 USPQ 90, 97                      
              (CCPA 1976).  In an effort to discharge that burden here, the examiner focuses on the                     
              language “a gaseous contrast agent” in claim 11.2  According to the examiner, the                         
              specification as filed does not describe spherical particles comprising a matrix of a                     
              biocompatible, biodegradable, non-immunogenic polymer enclosing a gaseous contrast                        
              agent which reflects sound waves.  Therefore, the examiner argues, applicants’ claims                     
              do not enjoy adequate, written descriptive support in the specification, as filed, and they               
              run afoul of the written description requirement in 35 U.S.C. 112, first paragraph.  We                   
              disagree.                                                                                                 
                     The language “a gaseous contrast agent” is not found verbatim in the original                      
              disclosure.  However, in order to satisfy the written description requirement, the                        
              disclosure as originally filed does not have to provide in haec verba support for the                     

                                                                                                                        
              2 Independent claim 11 was amended in its current form in Paper No. 8, received July 3, 1996.             






Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007